June 2010

Findings Related to Assessing Value for Private US Health Plans

July 14, 2010

The American Journal of Pharmacy Benefits

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.

Synchronization of Treatment With Erythropoiesis-Stimulating Agents and Chemotherapy

July 14, 2010

The American Journal of Pharmacy Benefits

In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.

Healthcare Reform, Comparative Effectiveness Research, and P&T Decisions

July 14, 2010

The American Journal of Pharmacy Benefits

The conduct and interpretation of comparative effectiveness research must build confidence that this research will enable improved access to appropriate healthcare interventions.

The Walmart $4 Challenge

July 14, 2010

The American Journal of Pharmacy Benefits

Programs offering $4 generics lower costs for both payers and healthcare consumers, but these medications should go through the claims system to enable tracking.